AstraZeneca is a United Kingdom-based company founded in 1999, operating within the manufacturing sector, specifically in pharmaceuticals. With a workforce exceeding 10,001 employees, the company generates substantial revenue, amounting to approximately $58.7 billion. AstraZeneca's published documents reflect a focus on health and safety, as evidenced by their document titled "Safety-health-and-the-environment," which likely outlines protocols and checklists related to workplace safety and environmental considerations in pharmaceutical manufacturing. Additionally, AstraZeneca engages in research related to healthcare improvements, as indicated by their involvement in the IHE Report 2024, which discusses endometrial cancer, its rising incidence, and associated health disparities. This report emphasizes the need for improved care and policy changes in the context of women's health, highlighting the impact of socioeconomic factors on diagnosis and survival rates. Overall, AstraZeneca's documentation underscores its commitment to health, safety, and advancing medical knowledge in the pharmaceutical industry.